These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


173 related items for PubMed ID: 21703192

  • 1. Chemical composition of hepatic lipids mediates reperfusion injury of the macrosteatotic mouse liver through thromboxane A(2).
    El-Badry AM, Jang JH, Elsherbiny A, Contaldo C, Tian Y, Raptis DA, Laczko E, Moritz W, Graf R, Clavien PA.
    J Hepatol; 2011 Dec; 55(6):1291-9. PubMed ID: 21703192
    [Abstract] [Full Text] [Related]

  • 2. Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids.
    El-Badry AM, Moritz W, Contaldo C, Tian Y, Graf R, Clavien PA.
    Hepatology; 2007 Apr; 45(4):855-63. PubMed ID: 17393510
    [Abstract] [Full Text] [Related]

  • 3. Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure and thromboxane A2 release in a rodent model of NASH-cirrhosis.
    Yang YY, Huang YT, Tsai TH, Hou MC, Lee FY, Lee SD, Lin HC.
    Clin Sci (Lond); 2012 Dec; 123(12):669-80. PubMed ID: 22734967
    [Abstract] [Full Text] [Related]

  • 4. Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury.
    Llacuna L, Fernández A, Montfort CV, Matías N, Martínez L, Caballero F, Rimola A, Elena M, Morales A, Fernández-Checa JC, García-Ruiz C.
    J Hepatol; 2011 May; 54(5):1002-10. PubMed ID: 21145825
    [Abstract] [Full Text] [Related]

  • 5. Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis.
    Selzner N, Selzner M, Jochum W, Amann-Vesti B, Graf R, Clavien PA.
    J Hepatol; 2006 Apr; 44(4):694-701. PubMed ID: 16229921
    [Abstract] [Full Text] [Related]

  • 6. Omega-3 fatty acids reduce hepatic steatosis and consequently attenuate ischemia-reperfusion injury following partial hepatectomy in rats.
    Marsman HA, Heger M, Kloek JJ, Nienhuis SL, ten Kate FJ, van Gulik TM.
    Dig Liver Dis; 2011 Dec; 43(12):984-90. PubMed ID: 21840275
    [Abstract] [Full Text] [Related]

  • 7. Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice.
    Fiorini RN, Donovan JL, Rodwell D, Evans Z, Cheng G, May HD, Milliken CE, Markowitz JS, Campbell C, Haines JK, Schmidt MG, Chavin KD.
    Liver Transpl; 2005 Mar; 11(3):298-308. PubMed ID: 15719408
    [Abstract] [Full Text] [Related]

  • 8. Dietary omega-3 polyunsaturated fatty acids attenuate hepatic ischemia/reperfusion injury in rats by modulating toll-like receptor recruitment into lipid rafts.
    Kim K, Jung N, Lee K, Choi J, Kim S, Jun J, Kim E, Kim D.
    Clin Nutr; 2013 Oct; 32(5):855-62. PubMed ID: 23395256
    [Abstract] [Full Text] [Related]

  • 9. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease.
    Alwayn IP, Gura K, Nosé V, Zausche B, Javid P, Garza J, Verbesey J, Voss S, Ollero M, Andersson C, Bistrian B, Folkman J, Puder M.
    Pediatr Res; 2005 Mar; 57(3):445-52. PubMed ID: 15659701
    [Abstract] [Full Text] [Related]

  • 10. The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet.
    Nakano H, Nagasaki H, Barama A, Boudjema K, Jaeck D, Kumada K, Tatsuno M, Baek Y, Kitamura N, Suzuki T, Yamaguchi M.
    Hepatology; 1997 Sep; 26(3):670-8. PubMed ID: 9303498
    [Abstract] [Full Text] [Related]

  • 11. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.
    Teoh NC, Ito Y, Field J, Bethea NW, Amr D, McCuskey MK, McCuskey RS, Farrell GC, Allison AC.
    Gastroenterology; 2007 Aug; 133(2):632-46. PubMed ID: 17681182
    [Abstract] [Full Text] [Related]

  • 12. Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice.
    Park HJ, DiNatale DA, Chung MY, Park YK, Lee JY, Koo SI, O'Connor M, Manautou JE, Bruno RS.
    J Nutr Biochem; 2011 Apr; 22(4):393-400. PubMed ID: 20655714
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of TXA synthesis with OKY-046 improves liver preservation by prolonged hypothermic machine perfusion in rats.
    Xu H, Lee CY, Clemens MG, Zhang JX.
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e212-20. PubMed ID: 17645480
    [Abstract] [Full Text] [Related]

  • 14. A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury.
    He S, Atkinson C, Evans Z, Ellett JD, Southwood M, Elvington A, Chavin KD, Tomlinson S.
    J Immunol; 2009 Oct 01; 183(7):4764-72. PubMed ID: 19752222
    [Abstract] [Full Text] [Related]

  • 15. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease.
    Hong F, Radaeva S, Pan HN, Tian Z, Veech R, Gao B.
    Hepatology; 2004 Oct 01; 40(4):933-41. PubMed ID: 15382116
    [Abstract] [Full Text] [Related]

  • 16. Omega 3 - Omega 6: What is right for the liver?
    El-Badry AM, Graf R, Clavien PA.
    J Hepatol; 2007 Nov 01; 47(5):718-25. PubMed ID: 17869370
    [Abstract] [Full Text] [Related]

  • 17. Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat.
    Serafín A, Roselló-Catafau J, Prats N, Xaus C, Gelpí E, Peralta C.
    Am J Pathol; 2002 Aug 01; 161(2):587-601. PubMed ID: 12163383
    [Abstract] [Full Text] [Related]

  • 18. The novel TLR9 antagonist COV08-0064 protects from ischemia/reperfusion injury in non-steatotic and steatotic mice livers.
    Shaker ME, Trawick BN, Mehal WZ.
    Biochem Pharmacol; 2016 Jul 15; 112():90-101. PubMed ID: 27157410
    [Abstract] [Full Text] [Related]

  • 19. The reduced tolerance of rat fatty liver to ischemia reperfusion is associated with mitochondrial oxidative injury.
    Caraceni P, Domenicali M, Vendemiale G, Grattagliano I, Pertosa A, Nardo B, Morselli-Labate AM, Trevisani F, Palasciano G, Altomare E, Bernardi M.
    J Surg Res; 2005 Apr 15; 124(2):160-8. PubMed ID: 15820243
    [Abstract] [Full Text] [Related]

  • 20. Thromboxane A2 in preservation-reperfusion injury: the effect of thromboxane A2 synthetase inhibitor.
    Suehiro T, Yanaga K, Itasaka H, Kishikawa K, Shirbe K, Shimada M, Sugimachi K.
    J Surg Res; 1996 May 15; 62(2):216-23. PubMed ID: 8632642
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.